North Crest Asset Manangement, LLC Biogen Inc. Transaction History
North Crest Asset Manangement, LLC
- $3.19 Billion
- Q4 2024
A detailed history of North Crest Asset Manangement, LLC transactions in Biogen Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 31,858 shares of BIIB stock, worth $4.64 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
31,858
Previous 31,858
-0.0%
Holding current value
$4.64 Million
Previous $6.18 Million
21.12%
% of portfolio
0.15%
Previous 0.19%
Shares
12 transactions
Others Institutions Holding BIIB
# of Institutions
995Shares Held
131MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.43 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.37 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.12 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.07 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$765 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...